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Background: Chewing areca nut (AN), also known as betel nut, is common in Asia and the South Pacific and the
habit has been linked to a number of serious health problems including oral cancer. Use of AN in pregnancy has
been associated with a reduction in mean birthweight in some studies, but this association and the relationship
between AN chewing and other adverse pregnancy outcomes remain poorly understood.
Methods: We assessed the impact of AN chewing on adverse outcomes including stillbirth, low birthweight
(LBW, <2,500 g) and anaemia at delivery (haemoglobin <11.0 g/dL) in a longitudinal cohort of 2,700 pregnant
women residing in rural lowland Papua New Guinea (PNG) from November 2009 until February 2013. Chewing
habits and participant characteristics were evaluated at first antenatal visit and women were followed until
delivery.
Results: 83.3 % [2249/2700] of pregnant women used AN, and most chewed on a daily basis (86.2 % [1939/2249].
Smoking and alcohol use was reported by 18.9 % (511/2700) and 5.0 % (135/2688) of women, respectively.
AN use was not associated with pregnancy loss or congenital abnormalities amongst women with a known
pregnancy outcome (n = 2215). Analysis of 1769 birthweights did not demonstrate an association between AN
and LBW (chewers: 13.7 % [200/1459] vs. non-chewers: 14.5 % [45/310], P = 0.87) or reduced mean birthweight
(2957 g vs. 2966 g; P = 0.76). Women using AN were more likely to be anaemic (haemoglobin <11 g/dL) at
delivery (75.2 % [998/1314] vs. 63.9 % [182/285], adjusted odds ratio [95 % CI]: 1.67 [1.27, 2.20], P < 0.001). Chewers
more commonly had male babies than non-chewers (46.1 % [670/1455] vs. 39.8 % [123/309], P = 0.045).
Conclusions: AN chewing may contribute to anaemia. Although not associated with other adverse pregnancy
outcome in this cohort gestational AN use should be discouraged, given the potential adverse effects on
haemoglobin and well-established long-term health risk including oral cancer. Future research evaluating the
potential association of AN use and anaemia may be warranted.
Trial registration: ClinicalTrials.gov NCT01136850 (06 April 2010).* Correspondence: marai.kaius@gmail.com
1Papua New Guinea Institute of Medical Research (PNG IMR), PO BOX 60,
Goroka, Eastern Highlands Province 411, Papua New Guinea
Full list of author information is available at the end of the article
© 2015 Ome-Kaius et al. Open Access This article is distributed under the terms of the Creative Commons Attribution
4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in
this article, unless otherwise stated.
Ome-Kaius et al. BMC Pregnancy and Childbirth  (2015) 15:177 Page 2 of 9Background
Areca nut (AN), also known as betel nut, is the fruit of
the Areca catechu Linn. palm tree. Across the globe,
approximately 600 million people use AN as a mastica-
tory drug, primarily in tropical and sub-tropical regions
of South-East Asia and the South Pacific [1, 2]. The
psycho-stimulatory effects of AN chewing are thought
to be mediated by the alkaloid arecoline [3, 4]. Other
alkaloids contained in AN, specifically guavacoline,
guavacine, arecaidine, may also play a role [5]. After
nicotine, alcohol and caffeine, arecoline from AN is the
most widely used addictive substance globally [1].
AN has been associated with oral cancer as a result of
exposure to carcinogenic derivatives of arecoline [5, 6].
Use also increases the risk of hypertension and arrhyth-
mias [7, 8], possibly due to the effects of arecoline on
the autonomic nervous system [3, 9], and has been
linked to endocrine disease such as diabetes [10, 11].
These adverse effects have been demonstrated in a range
of different geographical settings including Papua New
Guinea (PNG) [8, 12], where widespread AN use has
been reported [13–15].
AN use is not uncommon in pregnancy in most regions
where it is consumed [15–17]. This raises concerns about
its potentially detrimental effects on embryogenesis and
fetal growth, and hence AN use could represent an im-
portant target for public health interventions to reduce
the burden of low birthweight (LBW, birthweight <2500 g)
and infant mortality [18, 19]. AN has been associated with
reduction in birthweight in two pregnancy studies
undertaken in PNG [15, 20]. Similarly, AN consump-
tion was associated with reduced birthweight, reduced
fetal length as well as LBW in research from Taiwan
[16, 21, 22]. This research also identified an association
between AN use and miscarriage, stillbirth, preterm de-
livery (PTD, <37 gestational weeks) and increased
male-to-female ratio [16, 21, 22]. In contrast, two other
studies [17, 23] were unable to demonstrate deleterious
effects of AN use on pregnancy outcomes, birthweight
and anaemia in pregnancy.
In addition to study design and sample size, explanations
for the differences in the effect of AN on birthweight ob-
served between studies may include variations in how ANs
are prepared and chewed [2, 24]. In a number of settings
betel nut is chewed together with tobacco, and associations
with smokeless tobacco use and adverse birth outcomes are
well documented [21, 25]. Furthermore, it has been demon-
strated that availability and uptake of arecoline depends on
the degree of maturity of the nuts at the time of consump-
tion, the method of preparation, the contents of the ‘betel
quid’, and whether the quid is swallowed or spat out [5].
Betel quid describes the combination of AN with ingredi-
ents such as Piper betel leaves, slaked lime (calcium hydrox-
ide), tobacco, and sweet spices for consumption [1, 2, 26].In PNG, AN, locally known as ‘buai’, is usually chewed in
combination with the Piper betel fruit (known as ‘daka’)
and lime (known as ‘kambang’), the latter serving as a cata-
lyst [12, 15]. Unlike other regions, tobacco is not chewed in
PNG [27]. AN chewing is equally prevalent among men
and women in the adult PNG population [13, 28].
This study assessed the effects of AN chewing on
pregnancy outcomes, birthweight, and anaemia in a large
cohort of pregnant women enrolled before or at 26 ges-
tational weeks and followed until delivery.
Methods
Study design, setting and participants
This prospective cohort study of pregnant women was
conducted at nine health facilities in Madang Province on
the North East Coast of PNG. Women were enrolled be-
tween November 2009 and August 2012, and follow-up
was completed in February 2013. Participants were co-
enrolled in a clinical trial that evaluated the impact of
intermittent preventive treatment in pregnancy (IPTp)
with the combination of sulphadoxine-pyrimethamine and
azithromycin (SPAZ) on LBW [29]. The study area was
previously reported to have a high prevalence of AN use
[15], malaria and anaemia [30, 31], and LBW [15]. Ante-
natal HIV prevalence at Madang’s Modilon hospital was
1.1 % (34/3108) (2009–2012, unpublished audit data).
Women attending their first antenatal care visit were
provided with study information and invited to participate.
Interested women were screened for eligibility and
were excluded if they had i) symphysis-pubis fundal
height >26 cm, ii) haemoglobin (Hb) <6 g/dL and were
symptomatic as a result of anaemia, iii) previous ad-
verse reaction to study medications, iv) permanent dis-
ability preventing participation, v) known multiple
pregnancy, vi) unavailable for follow-up, viii) not preg-
nant, ix) residing out with study area, or x) unable to
report on AN use. Routine clinical assessments were
performed and socio-demographic and clinical data
were collected at enrolment using standardized case
report forms. Participants were screened for syphilis
and anaemia. HIV counseling and testing was provided
at participating health centers but information on serosta-
tus was not collected as part of this study. Women present-
ing with signs and symptoms of malaria or Hb <9 g/dL
(HemoCue, Ängelholm, Sweden; accuracy of 0.1 g/dL)
were tested using a malaria rapid diagnostic test (CareS-
tart™ Pf/Pv combo test, AccessBio, USA). Malaria and an-
aemia were treated with artemether/lumefantrine (2nd &
3rd trimester) or quinine (first trimester), and women with
Hb <9 g/dL were provided with iron/folate supplements
(Fefol 2 tabs once daily) and albendazole (400 mg stat), as
per national guidelines [32]. In addition, peripheral blood
smears were prepared at enrolment and subsequent IPTp
visits (2), at delivery, and during passive case detection
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burden only. Participants were scheduled for an obstetric
ultrasound examination (Logiqbook XP, General Electric
Medical Systems, UK) to date their pregnancy: we were
unable to offer scans to all women for operational reasons.
Study participants were followed up until delivery
when information on the outcome of pregnancy and
birthweight was collected.
Measures
The primary outcome measures of the study were LBW
and mean birthweight. Secondary outcomes included
anaemia and mean arterial pressure at delivery, PTD,
neonatal length, miscarriage, stillbirth, congenital ab-
normalities, and infant sex.
Maternal AN use (exposure) was evaluated at enrol-
ment and based on information reported by participants.
We enquired whether women chewed or not, and subse-
quently evaluated the frequency of chewing, with women
estimating their average number of ANs chewed per day.
Serum arecoline levels were not measured. Amongst
chewers, we estimated the number of ANs chewed per
day as ‘less than one nut per day’, ‘1-2 nuts per day’, ‘3–5
nuts per day’ and ‘more than 6 nuts per day’, we as-
sumed chewing patterns as reported at baseline would
continue during pregnancy [15, 20].
Potential confounders/effect modifiers were measured
and included smoking, gravidity, malaria, alcohol use,
ethnicity/regional origin, residence, literacy level (defined
as no education or education less than grade 3), income
(participant and partner), maternal nutritional status, bed
net use, maternal height, frequency of antenatal clinic
visits, receipt of IPTp, infant gender and timing of birth-
weight/haemoglobin measurement.
Smoking and alcohol consumption during the index
pregnancy were evaluated at enrolment only. Question-
naires did not quantify intake or characterize types of to-
bacco smoked and alcohol products consumed.
Research nurses measured birthweight using an elec-
tronic infant scale (Cupid 1, Charder Medical, Taiwan,
precision 10 g); only birthweights measured within 24 h
of delivery were used in analyses.
Miscarriage was defined as a delivery <22 weeks gesta-
tion or birthweight <500 g [29]. Neonatal anthropometry
included head circumference, length and abdominal cir-
cumference, and newborns were examined for congeni-
tal malformations.
PTD was defined as a delivery before 37 gestational
weeks [33]. Last menstrual period and Ballard scores
were highly unreliable in accurately estimating gesta-
tional age in our cohort (data not shown). Therefore, the
potential impact of AN use on PTD was only assessed
amongst women who had ultrasound-based pregnancy
dating.At delivery, Hb levels and blood pressure (Automatic
Blood Pressure Monitor, Omron, Australia) were mea-
sured. Anaemia was defined as an Hb <11 g/dL [34], and
mean arterial pressure (diastolic pressure plus one third
of pulse pressure) was calculated.
Malarial infection was defined as detection of parasit-
aemia in peripheral venous blood by light microscopy.
Blood smears were examined as previously described [29].
Clinical staff assessing primary and secondary out-
comes were not told of women’s chewing status as re-
ported at enrolment; however complete blinding was
impossible given the effect of frequent chewing on den-
tal health.
Statistical analysis
Data was doubled-entered into a study database (Fox-
Pro 9.0, Microsoft, USA) and analysed using Stata 12.0
(StataCorp, USA).
Continuous parametric data was described as mean ±
standard deviation (SD), continuous nonparametric data
as median and interquartile range (IQR) and categorical
data as % (n). When comparisons of variables across all
five groups remained significant after Bonferroni adjust-
ments, pairwise comparisons of the different chewing
level groups against non-chewers were performed using
the two-sided student’s t-test for parametric data, the
Mann Whitney-U test for nonparametric data, and the
Chi-squared or Fisher’s exact test for comparison of pro-
portions. Multi-group comparisons were performed
using ANOVA for normally distributed data, the
Kruskal-Wallis test for continuous non-parametric data
and the Chi-squared or Fisher’s exact test for compari-
son of proportions. Matched parametric data was com-
pared using the paired t-test.
Birthweight analyses only included congenitally nor-
mal live born singleton infants with a weight measured
within 24 h of delivery. Associations between AN,
smoking, malaria, alcohol use, ethnic origin, residence,
literacy level, income (participant and partner), gravid-
ity, nutritional status, bed net use, height, frequency of
antenatal clinic visits, receipt of IPTp, and infant gen-
der with birthweight/LBW as well as anaemia at deliv-
ery (Hb <11 g/dL) were assessed. Covariates with P < 0.1
were included in a multivariate logistic regression model
(LBW, anaemia) or linear regression (birthweight) as a
starting model for a backward stepwise elimination model
selection procedure and considered independent risk fac-
tors if P < 0.05. Tests for interaction between AN use and
gravidity (categorised as primigravida, multigravida),
height (categorised as low [<150 cm] and normal height
[≥150 cm]), and participant’s ethnic grouping (categorized
as highlander parentage and non-highlander parentage)
were performed on the bivariate models for LBW and an-
aemia using the likelihood ratio test.
Enrolled into IPTp trial: 2793
Followed-up for pregnancy outcome: 2215
o Excluded: Incomplete consent form = 18 
o Excluded: Trial protocol deviation = 55 
o Excluded: Unknown chewing status =  20 
o Withdrawn = 43 
Birthweight available: 1769
Miscarriage = 6 
Stillbirth = 40 
Congenital abnormality = 17 
Twins = 4 
Weight measured >24 hours postpartum = 376 
Unregistered birthweight = 3 
Enrolled in areca nut study: 2700 
o Lost to follow-up = 442 
Fig. 1 Participant flow diagram
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women with complete data (imputation was not per-
formed). Background characteristics and chewing habits
of women lost to follow-up were compared to those in-
cluded in analyses to assess internal validity. External
validity of the cohort is discussed elsewhere [29]. A for-
mal sample size calculation for this study was not per-
formed, as women were co-enrolled in a clinical trial
that was powered to evaluate the effect of IPTp with
SPAZ on LBW [29].
Ethics
Ethical approval for this research was obtained from the
PNG Institute of Medical Research Institutional Review
Board (0815), the PNG Medical Research Advisory
Council (08.01) and the Melbourne Health Human Re-
search Ethics Committee (2008.162). The original trial
was registered with the United States National Institutes
of Health Clinical Trials Registry (NCT01136850). All
participants provided informed written consent.
Results
A total of 2700 women were enrolled in the study
(Fig. 1). Overall, 50.2 % (1354/2697) of women were
primigravid, 62.6 % (1685/2691) resided in rural areas,
81.8 % (2107/2577) were anaemic, 89.2 % (2404/2694)
were illiterate (defined as no education or less than
grade 3) and 55.7 % (1428/2562) pursued an income-
generating activity.
The prevalence of AN use was high (83.3 %; 2249/
2700), with the largest number of women using 3–5
ANs per day. Baseline characteristics of AN users dif-
fered from non-users (Table 1). Tobacco smoking and
alcohol use was reported by 18.9 % (511/2700) and
5.0 % (135/2688) of women, respectively, and both were
more common among AN users (Table 1). Relatively
few women of Highlands origin use AN, and non-users
were less commonly anaemic at enrolment compared
to users (Table 1). Heavy users (≥6 nuts/day) were less
likely to be primigravid compared to light chewers and
non-chewers (38.5 % [213/553] vs. 53.1 % [1141/2147],
P <0.001) (Table 1).
A total of 2215 women (82.0 % of enrolled) completed
follow-up and had pregnancy outcome data recorded
(Fig. 1). Women who were lost to follow-up (n = 485)
were more likely to be primigravid (56.0 % [271/484] vs.
48.9 % [1083/2213], P = 0.005) but did not differ in their
AN use compared to those women with known preg-
nancy outcomes (P >0.1 for the comparison of users
against non-users and comparison across all 5 groups).
Table 2 shows the associations between AN use and
birth outcomes. There were no associations between AN
use and stillbirth, miscarriage or prevalence of congeni-
tal abnormalities A total of 1769 women had infantweights that were eligible for inclusion in the birth-
weight analysis (Fig. 1). The overall prevalence of LBW
was 13.9 % (245/1769). There were no statistically sig-
nificant differences in the prevalence of LBW and PTD
by AN chewing status (Table 2).
Table 3 summarises associations of maternal and in-
fant characteristics with birthweight. The mean differ-
ence in birthweight between non-users and AN users
was −9 g (95 % CI −67, 49; P =0.76) (Table 3). Similarly,
adjusted multivariate analyses did not demonstrate an
effect of AN use on LBW or mean birthweight (Table 3).
Smoking was not independently associated with an in-
creased risk of LBW or reduced birthweight. There was
no statistically significant difference between women
who neither smoked or chewed, women who did not
smoke but chewed, and women who both smoked and
chewed in terms of LBW (14.7 % [43/292] vs. 13.2 %
[149/1128] vs. 15.9 % [53/349], P = 0.58) or mean birth-
weight (2964 vs. 2964 vs. 2934 g, P = 0.58).
Women using AN were more likely to be anaemic at de-
livery on crude (OR [95 % CI]: 1.66 [1.72, 2.25], P < 0.001,
n = 1599) and adjusted analysis (OR [95 % CI]: 1.67 [1.27,
2.20]) (Table 4). Amongst women with complete data for
haemoglobin and with a dating ultrasound (n = 1053)
gestational age at delivery was not associated with
Table. 1 Enrolment characteristics of pregnant women and association with areca nut use (n = 2700)
Characteristics Non-users Occasional users
(<1/day)
Mild users
(1-2/day)
Moderate users
(3–5/day)
Heavy users
(≥6/day)
Pa Pb
Areca nut 16.7 (451) 11.5 (310) 24.1 (650) 27.3 (736) 20.5 (553) - -
Smoking 5.3 (24/451) 13.6 (42/310) 16.2 (105/650) 22.0 (162/736) 32.2 (178/553) <0.001 <0.001
Alcohol 2.5 (11/444) 5.2 (16/309) 4.9 (32/649) 5.6 (41/735) 6.4 (35/551) 0.07 0.007
Rural residence 57.0 (257/451) 56.5 (175/310) 63.7 (414/650) 63.7 (469/736) 66.9 (370/553) 0.003 0.009
Highlands origin 12.2 (55/451) 8.4 (26/310) 4.6 (30/650) 4.8 (35/736) 4.0 (22/553) <0.001 <0.001
Literate 89.6 (404/451) 90.9 (281/309) 89.4 (580/649) 89.9 (660/734) 86.9 (479/551) 0.36 0.80
Generates income 50.1 (221/441) 55.7 (165/296) 57.4 (347/605) 57.9 (402/694) 55.7 (293/526) 0.11 0.009
Anaemia (Hb < 11 g/dL) 73.4 (318/433) 82.7 (239/289) 81.9 (514/628) 84.1 (590/702) 85.0 (446/525) <0.001 <0.001
Malariac 6.7 (30/449) 10.0 (31/310) 8.3 (54/648) 7.0 (51/734) 5.3 (29/551) 0.09 0.62
Primigravidae 52.8 (238/451) 62.6 (194/310) 58.5 (380/650) 44.7 (329/736) 38.5 (213/553) <0.001 0.22
MUAC <23 cm 26.3 (115/437) 17.1 (52/304) 31.3 (200/639) 30.0 (215/716) 27.1 (148/547) <0.001 0.50
Age (years) 24.0 [20.0–28.0] 23.0 [20.0–26.0] 22.0 [19.0–26.0] 24.0 [20.0–28.0] 25.0 [21.0–29.0] <0.001 0.22
Haemoglobin (g/dL) 9.9 [9.2–11.0] 9.8 [9.0–10.6] 9.6 [8.8–10.6] 9.6 [8.8–10.4] 9.5 [8.6–10.3] <0.001 <0.001
Mean arterial pressure 78.0 [71.7–84.3] 77.7 [72.0–84.7] 78.0 [71.7–83.7] 77.0 [71.0–83.3] 76.0 [69.7–82.0] 0.004 0.16
Fundal height (cm) 22.0 [18.0–24.0] 22.0 [19.0–24.0] 22.0 [19.0–24.0] 22.0 [20.0–24.0] 22.8 [20.0–24.0] <0.001 0.006
NOTE: Data are % (no. /total), or median [IQR]; p-values are for comparisons across the different groups of chewers. MUAC mid-upper arm circumference
aP-values for comparison across all 5 groups. Bonferroni adjusted cut-off of significance: P = 0.005
bP-values for comparison of users (occasional, mild, moderate, heavy) versus non-users
cBy light microscopy, any Plasmodium spp
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final multivariate model the association between AN
use and anaemia at delivery remained significant (OR
[95 % CI]: 1.87 [1.35, 2.59], P < 0.001, n = 1053). There
was an interaction between gravidity and AN use on
anaemia at delivery (P = 0.027): the negative impact of
chewing on anaemia appeared more profound amongstTable 2 Pregnancy and delivery outcomes according to areca nut u
Outcomes Non-users Occasional users
(<1 nut/d)
Mild Us
(1-2 nu
Miscarriage 0.5 (2/371) 0.0 (0/254) 0.6
Stillbirth 1.1 (4/371) 1.6 (4/254) 1.9
Congenital abnormality 1.4 (5/371) 0.4 (1/254) 0.6
Birthweight (g) 2966 [493] 2996 [507] 2928
LBW (<2,500 g) 14.5 (45/310) 13.8 (29/210) 15.1
Gestational age
(exact weeks)
39.4 [1.6] 39.2 [1.5] 39.5
PTD (<37 weeks) 6.6 (14/212) 7.7 (11/143) 8.6
Male infant 39.1 (123/309) 44.0 (92/209) 44.2
Cord haemoglobin
(Hb), g/dL
13.8 [2.3] 14.3 [2.4] 13.8
Hb, g/dL 10.5 [1.7] 10.3 [1.7] 10.1
Hb <11 g/dL 63.9 (182/285) 72.7 (141/194) 74.0
MAP (mmHg) 85.5 [79.3–93.3] 87.3 [80.0–95.7] 86.6
NOTE: Data are % (n), mean [standard deviation], or median [interquartile range]. LB
aP-values for comparison across all 5 groups. Bonferroni adjusted P-value: 0.005
bP- values for comparison of users (occasional, mild, moderate, heavy) versus non-umultigravidae (chewers: 78.1 % [523/670] vs. non-
chewers: 59.5 % [78/131], P < 0.001) compared to primi-
gravidae (chewers: 72.2 % [465/644] vs. non-chewers:
67.5 % [104/154], P =0.25).
Amongst women who had data for haemoglobin levels
at both enrolment and delivery (n = 1534) mean Hb
levels were higher at delivery compared to enrolmentse
ers
ts/d)
Moderate Users
(3–5 nuts/d)
Heavy users
(>5 nuts/d)
Pa Pb
(3/539) 0.2 (1/590) 0.0 (0/461) 0.34 0.27
(10/539) 2.2 (13/590) 2.0 (9/461) 0.80 0.39
(3/539) 0.5 (3/590) 1.1 (5/461) 0.52 0.19
[460] 2955 [468] 2971 [457] 0.49 0.76
(64/424) 12.1 (57/470) 14.1 (50/355) 0.76 0.71
[1.6] 39.3 [1.9] 39.4 [1.6] 0.69 0.84
(21/245) 7.8 (23/308) 8.4 (20/239) 0.95 0.46
(187/423) 48.2 (226/469) 46.6 (165/354) 0.21 0.045
[2.6] 13.6 [2.5] 13.8 [2.3] 0.27 0.98
[1.7] 9.9 [1.7] 10.0 [1.6] <0.001 <0.001
(279/377) 76.9 (326/424) 75.9 (242/319) 0.002 <0.001
[80.0–94.0] 84.0 [78.3–92.0] 84.7 [78.3–92.0] 0.003 0.41
W low birthweight, PTD preterm delivery, MAP, mean arterial pressure
sers
Table 3 Maternal and infant characteristics and association with birthweight (n = 1,769)
Factors Low birthweight P Adjusted odds ratio (95 % CI)e P Birthweight (g) Δ P Adjusted Δe P
Areca nut Yes 200/1459 (13.7) 2957
No 45/310 (14.5) 0.71 0.94 (065, 1.38) 0.77 2966 −9 0.76 −1 0.97
Smoking Yes 53/349 (15.2) 2935
No 192/1420 (13.5) 0.42 - 2694 −29 0.30 -
Malariaa Yes 24/194 (12.4) 2923
No 221/1575 (14.0) 0.53 - 2963 −40 0.27 -
Highlanderb Yes 6/111 (5.4) 3263
No 239/1,658 (14.1) 0.008 0.34 (0.14, 0.80) 0.013 2938 325 <0.001 311 <0.001
Primigravida Yes 175/869 (20.1) 2844
No 70/900 (7.8) <0.001 2.91 (2.13, 3.96) <0.001 3048 −214 <0.001 −214 <0.001
Generating Yes 148/1,215 (12.2) 2978
incomec No 92/535 (17.2) 0.005 0.77 (0.57, 1.05) 0.09 2919 59 0.016 22 0.35
Bed net used Regular 160/1253 (12.8) 2961
Irregular 84/513 (16.4) 0.046 0.77 (0.56, 1.05) 0.10 2954 7 0.78 16 0.51
Height <150 cm Yes 61/317 (19.2) 2827
No 180/1423 (12.7 0.002 1.71 (1.22, 2.41) 0.002 2987 −160 <0.001 −151 <0.001
MUAC <23 cm Yes 85/471 (18.1) 2861
No 155/1260 (12.3) 0.002 1.49 (1.10, 2.03) 0.010 2994 −133 <0.001 −99 <0.001
Antenatal visits 1-2 60/316 (19.0) 2889
≥3 185/1453 (12.7) 0.004 0.65 (0.46, 0.92) 0.014 2973 −84 0.004 −73 0.010
SPAZ-IPTp Yes 107/892 (12.0) 2974
No 138/877 (15.7) 0.023 0.64 (0.48, 0.85) 0.003 2942 32 0.15 44 0.041
Female infant Yes 158/971 (16.3) 2925
No 86/793 (10.8) 0.001 1.64 (1.22, 2.22) 0.001 2999 −74 0.001 −78 <0.001
Note: Data are n (%). CI confidence interval, MUAC mid-upper arm circumference
aPeripheral parasitaemia at any stage during pregnancy, by light microscopy
bBoth maternal parents are from highlands region
cPartner
dInsecticide-treated and untreated nets combined, irregular users include 9 non-users
eModel includes 1680 observations
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mean change in Hb levels between the two time points
did not differ between chewers and non-chewers in
crude analysis (0.38 vs. 0.38 g/dL, P > 0.99) or in an ana-
lysis that adjusted for time difference between measure-
ments (P = 0.71).
Discussion
Our research represents the second largest study of
the impact of AN chewing in pregnancy on birth out-
comes, and is the most comprehensive for PNG. In a
cohort of 2,700 pregnant women with a high propor-
tion of AN users (83.3 %), most of whom were regular
users (86.2 %), chewing AN was associated with an-
aemia at enrolment and delivery but not with adverse
pregnancy outcomes such as LBW and stillbirth. The
prevalence of gestational AN use was comparable to
that observed previously in pregnant women in coastalPNG [15, 20, 35], and is similar to use amongst the
general population [13, 28].
The majority of studies that have previously evaluated
the effect of AN consumption on the health of mother
and baby originate from PNG and Taiwan [15, 16, 20–22].
They have reported significant associations between ma-
ternal AN chewing and reduction in mean birthweight
[15, 16, 20], lower male newborn rate, lower birth length
and higher prevalence of LBW [16] and increased risks of
pregnancy loss [21, 22]. Observations from these earlier
studies stand in contrast to findings from this research
and those of the largest population study of AN use in
pregnancy conducted to date (Thailand) [17], neither of
which demonstrated an association between AN and
adverse pregnancy outcomes such as LBW and preg-
nancy loss. This comes in spite of significant differences
in chewing practices and participant characteristics be-
tween cohort studies with regards to AN consumption
Table 4 Maternal characteristics and anaemia (haemoglobin <11 g/dL) at delivery (n = 1,599)
Factors Anaemia Odds ratio (95 % CI) P Adjusted ORc (95 % CI) P
Areca nut Yes 988/1314 (75.2)
No 182/285 (63.9) 1.72 (1.31, 2.25) <0.001 1.67 (1.27, 2.20) <0.001
Smoking Yes 234/315 (74.3)
No 936/1284 (72.9) 1.07 (0.81, 1.42) 0.62 -
Malariaa Yes 141/178 (79.2)
No 1029/1421 (72.4) 1.45 (0.99, 2.12) 0.06 1.45 (0.99, 2.12) 0.06
Highlanderb Yes 67/103 (65.1)
No 1103/1496 (73.7) 0.66 (0.44, 1.01) 0.06 0.74 (0.48, 1.14) 0.17
Primigravida Yes 569/798 (71.3)
No 601/801 (75.3) 0.83 (0.66, 1.03) 0.08 0.85 (0.67, 1.04) 0.11
Height <150 cm Yes 201/289 (69.6)
No 952/1286 (74.0) 0.80 (0.61, 1.06) 0.12 -
MUAC <23 cm Yes 316/420 (75.2)
No 824/1143 (72.1) 1.18 (0.91, 1.52) 0.22 -
Generates income Yes 617/829 (74.4)
No 493/692 (71.2) 1.17 (0.94, 1.47) 0.16 -
≥3 antenatal visits Yes 950/1310 (75.5)
No 220/289 (76.1) 0.82 (0.62, 1.11) 0.21 -
SPAZ-IPTp Yes 583/800 (72.9)
No 587/799 (73.5) 0.97 (0.78, 1.21) 0.79 -
Note: Data are n (%). CI confidence interval. MUAC mid-upper arm circumference
aPeripheral parasitaemia during pregnancy, by light microscopy
bBoth maternal parents from highlands region
cModel includes 1596 number of observations
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fered: most women in the Thai study were occasional/
light AN users, whilst most PNG women were regular,
if not heavy users. Second, the prevalence of smoking
differed considerably. Smoking was more common in
the Thai cohort (~38 % vs. 19 % in PNG) where it re-
duced mean birthweight, whilst the habit was not asso-
ciated with lower mean birthweight in the present
study (−29 g, P = 0.30).
Observations from our study and Thailand suggest
that the deleterious effect of AN use on pregnancy out-
comes is perhaps less pronounced at the population level
than previously suggested. Larger population cohort
studies have more power to detect true associations and
are less prone to selection bias (e.g. preferential recruit-
ment of heavy chewers that may have concomitant risk
factors of adverse birth outcomes) [36] which may partly
explain why more recent, larger cohort studies on AN
use in pregnancy did not replicate the findings of previ-
ous, smaller, studies. Furthermore, previous research did
not control for confounders such as parity [16], malaria
and maternal undernutrition [15, 20] and substance
abuse [16, 21]. Earlier studies from PNG were conducted
prior to intensified malaria control, and malaria inpregnancy was common [37] whereas malaria prevalence
was comparatively low in this cohort and hence less
likely to be a potential confounder of the AN-
birthweight relationship. Additionally, AN use may
largely be associated with adverse pregnancy outcomes
only amongst women with pre-existing health problems
or presence of risk factors, an observation which could
be missed by large cohort studies. Population-based
studies and studies identifying at-risk women, as well as
research evaluating the physiological effects of chewing
on e.g. utero-placental blood flow, will assist with broad-
ening our understanding of the effects of AN use in
pregnancy and may help consolidate the findings of re-
cent large cohort studies.
A novel observation in this study was the association
of AN use with anaemia at enrolment and delivery,
which persisted after adjusting for other factors associ-
ated with haemoglobin levels including malaria, gravid-
ity, socioeconomic factors, maternal undernutrition and
ethnicity. This is important as anaemia has been associ-
ated with adverse pregnancy outcomes [38], increases
the risk of heart failure, and reduces a woman's reservoir
to withstand the consequence of postpartum haemor-
rhage. In Thailand, AN use was associated with anaemia
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geneity in participant characteristics and chewing inten-
sity between these studies may be one explanation. It is
also possible that we did not measure and adjust for
all relevant confounders of the AN-anaemia relationship.
Assuming that the association between AN chewing and
anaemia is real and confirmed in future studies, poten-
tial mechanisms as to how AN use affects haemoglobin
remain to be elucidated. Arecoline has been shown to
modify appetite [39] which may result in a global reduc-
tion of food intake including essential nutrients such as
iron, thereby increasing the risk of iron-deficiency an-
aemia. AN has also been associated with irritation of the
lower oesophagus and gastritis [40] which may result in
chronic blood loss and iron-deficiency anaemia. Further-
more, components of the betel nut quid may, if swal-
lowed, alter the ability of the gastrointestinal tract to
absorb nutrients such as iron. Further research into po-
tential mechanisms may be warranted, and pregnant
women with anaemia should receive advice about stop-
ping chewing of AN. The effect of chewing on Hb levels
was most pronounced amongst multigravidae, which
may be explained by the fact these women are more
likely to be heavy users and are likely to have been chew-
ing AN for longer (chronic exposure). Finally, there was
no statistically significant difference in the change in Hb
levels from enrolment until delivery by chewing status.
This suggests that it is the effect of AN use on haemo-
globin levels before pregnancy that by and large dictates
the association between AN and anaemia at delivery.
We observed a higher proportion of male infants
amongst AN users compared to non-users. This is not
the first time such an association was observed, although
previous research suggested a reduction in the male-to-
female sex ratio amongst chewers [16]. Heavy cigarette
smoking has also been shown to affect the sex ratio at
birth [41]. Potential mechanisms that could explain such
observations include differential effects of AN on sper-
matozoae (but we did not document AN use of partner)
or embryo survival [22], although most AN studies, in-
cluding ours, did not observe an association of AN use
with miscarriage and stillbirth.
Strengths of this study include a large cohort size, de-
tailed information on chewing habits and participant
characteristics, and a comprehensive assessment of the
effect of AN use on a number of adverse pregnancy out-
comes and maternal anaemia. Our study has limitations.
Firstly, AN use was only assessed at first antenatal visit,
and chewing habits may have changed through the
course of pregnancy, which may introduce bias. Second,
AN use was self-reported and was not corroborated by
arecoline blood levels. Third, we did not evaluate quan-
tity and type of tobacco use. It is plausible that smoking
was not associated with birthweight in this study, andanother study from the same area [15], because of infre-
quent consumption or type of tobacco used. However, of
concern is that proportion of women smoking in preg-
nancy appears to have doubled within five years (9 % vs.
18 %) [15]. Fourth, we may not have measured all factors
associated with our outcome measures (e.g. indoor pol-
lution, iron/folate supplementation and adherence), and
residual confounding may explain some of our findings.
Furthermore, gestational length could only be adequately
assessed (by ultrasound) in a subset of women, increas-
ing the risk of selection bias and requiring cautious in-
terpretation of these data. Lastly, we did not perform
detailed full blood counts and measurements of iron and
folate concentrations, precluding a more detailed charac-
terisation of anaemia in our cohort.
Although the present study was unable to demonstrate
an association between AN chewing and adverse birth
outcomes, we observed an increased risk of anaemia
amongst chewers. Further evaluation of this association
is required. Irrespective of the apparent absence of
harmful effects of AN on pregnancy shown in this study,
the relationship between chronic exposure to AN and
other serious health problems (cancer in particular) has
been well established and this calls for strategies to re-
duce AN use. In settings where resources are limited,
antenatal care should focus on, and prioritize interven-
tions that target other known and preventable causes of
adverse pregnancy outcomes such as malaria and to-
bacco smoking, whilst raising awareness of the known
adverse effects of AN.Conclusions
The present study was unable to demonstrate significant
associations between AN use in pregnancy and reduced
birthweight and pregnancy loss. However, AN use was
associated with lower haemoglobin levels at first ante-
natal visit and delivery, and appeared to affect the male-
to-female sex ratio. Gestational AN use should be
discouraged, given the potential adverse effects on
haemoglobin and well-established long-term health risk
including oral cancer. Future research evaluating the po-
tential association of AN use and anaemia may be
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